AAAAAA
Results:
1-16
|
Results: 16
Authors:
Pande, KC
Ashford, RU
Dey, A
Kayan, K
McCloskey, EV
Kanis, JA
Citation: Kc. Pande et al., Atypical familial Paget's disease of bone, JOINT BONE, 68(3), 2001, pp. 257-261
Authors:
Ashford, RU
Luchetti, M
McCloskey, EV
Gray, RL
Pande, KC
Dey, A
Kayan, K
Ralston, SH
Kanis, JA
Citation: Ru. Ashford et al., Studies of bone density, quantitative ultrasound, and vertebral fractures in relation to collagen type I alpha 1 alleles in elderly women, CALCIF TIS, 68(6), 2001, pp. 348-351
Authors:
McCloskey, EV
Guest, JF
Kanis, JA
Citation: Ev. Mccloskey et al., The clinical and cost considerations of bisphosphonates in preventing bonecomplications in patients with metastatic breast cancer or multiple myeloma, DRUGS, 61(9), 2001, pp. 1253-1274
Authors:
McCloskey, EV
Dunn, JA
Kanis, JA
MacLennan, ICM
Drayson, MT
Citation: Ev. Mccloskey et al., Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma, BR J HAEM, 113(4), 2001, pp. 1035-1043
Authors:
Pande, KC
Bernard, J
McCloskey, EV
de Takats, D
Kanis, JA
Citation: Kc. Pande et al., Ultrasound velocity and dual-energy X-ray absorptiometry in normal and pagetic bone, BONE, 26(5), 2000, pp. 525-528
Authors:
Selby, PL
McCloskey, EV
Robinson, J
Smith, IG
Potts, B
Beneton, MNC
Kanis, JA
Citation: Pl. Selby et al., Is a calculated total hip BMD of clinical use?, OSTEOPOR IN, 11(4), 2000, pp. 368-371
Authors:
Dey, A
McCloskey, EV
Taube, T
Cox, R
Panda, KC
Ashford, RU
Forster, M
de Takats, D
Kanis, JA
Citation: A. Dey et al., Metacarpal morphometry using a semi-automated technique in the assessment of osteoporosis and vertebral fracture risk, OSTEOPOR IN, 11(11), 2000, pp. 953-958
Authors:
Pande, KC
de Takats, D
Kanis, JA
Edwards, V
Slade, P
McCloskey, EV
Citation: Kc. Pande et al., Development of a questionnaire (OPQ) to assess patient's knowledge about osteoporosis, MATURITAS, 37(2), 2000, pp. 75-81
Authors:
Kanis, JA
McCloskey, EV
Citation: Ja. Kanis et Ev. Mccloskey, Bisphosphonates in the treatment of multiple myeloma, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 457-481
Authors:
Kanis, JA
McCloskey, EV
Citation: Ja. Kanis et Ev. Mccloskey, Effect of calcitonin on vertebral and other fractures, QJM-MON J A, 92(3), 1999, pp. 143-149
Authors:
Kanis, JA
McCloskey, EV
de Takats, D
Pande, K
Citation: Ja. Kanis et al., Clinical assessment of bone mass, quality and architecture, OSTEOPOR IN, 9, 1999, pp. 24-28
Authors:
McCloskey, EV
Bone, H
Rodan, G
McClung, M
Wallach, S
Lyles, KW
Grauer, A
Mautelan, C
Gutteridge, DH",Anderson,Hooper,Ralston,Sharpe,Posen
Citation: Ev. Mccloskey et al., Newer bisphosphonates in the treatment of Paget's disease of bone: Where we are and where we want to go - Discussion, J BONE MIN, 14, 1999, pp. 74-78
Authors:
O'Neill, TW
McCloskey, EV
Kanis, JA
Bhalla, AK
Reeve, J
Reid, DM
Todd, C
Woolf, AD
Silman, AJ
Citation: Tw. O'Neill et al., The distribution, determinants, and clinical correlates of vertebral osteophytosis: A population based survey, J RHEUMATOL, 26(4), 1999, pp. 842-848
Authors:
Bruce, NJ
McCloskey, EV
Kanis, JA
Guest, JF
Citation: Nj. Bruce et al., Economic impact of using clodronate in the management of patients with multiple myeloma, BR J HAEM, 104(2), 1999, pp. 358-364
Authors:
Kanis, JA
McCloskey, EV
Powles, T
Paterson, AHG
Ashley, S
Spector, T
Citation: Ja. Kanis et al., A high incidence of vertebral fracture in women with breast cancer, BR J CANC, 79(7-8), 1999, pp. 1179-1181
Authors:
Kanis, JA
McCloskey, EV
Citation: Ja. Kanis et Ev. Mccloskey, Risk factors in osteoporosis, MATURITAS, 30(3), 1998, pp. 229-233
Risultati:
1-16
|